These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1. Cheung M; Kuntz KW; Pobanz M; Salovich JM; Wilson BJ; Andrews CW; Shewchuk LM; Epperly AH; Hassler DF; Leesnitzer MA; Smith JL; Smith GK; Lansing TJ; Mook RA Bioorg Med Chem Lett; 2008 Dec; 18(23):6214-7. PubMed ID: 18929484 [TBL] [Abstract][Full Text] [Related]
4. [The pharmacological properties of preparations from the aziridinyl triazine group]. Stukov AN; Filov VA; Kon'kov SA; Ivin BA Eksp Klin Farmakol; 1996; 59(1):58-60. PubMed ID: 8704637 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and chemistry of fluorine containing bioactive 1,2,4-triazines--an overview. Chemistry of uncondensed 1,2,4-triazines, Part III. Abdel-Rahman RM Pharmazie; 1999 Nov; 54(11):791-803. PubMed ID: 10603605 [TBL] [Abstract][Full Text] [Related]
6. Some substituted imidazo[1,2-b] [1,2,4]triazines and 8H-pyrimido[1,2-b] [1,2,4]triazin-8-ones as potential antineoplastic agents. Labouta IM; Soliman FS; Kassem MG Pharmazie; 1986 Nov; 41(11):812-3. PubMed ID: 3562515 [No Abstract] [Full Text] [Related]
7. [Methodical aspects in studies on the carcinogenesis and chemotherapy of tumors]. Schmähl D Planta Med; 1968; ():3-12. PubMed ID: 4976078 [No Abstract] [Full Text] [Related]
8. [On some biological effects of the cytostatic agent verrucarin A]. Rüsch ME; Stähelin H Arzneimittelforschung; 1965 Aug; 15(8):893-7. PubMed ID: 4955716 [No Abstract] [Full Text] [Related]
9. Antitumor and hyperglycemic activity of streptozotocin (NSC-37917) and its cofactor, U-15,774. Evans JS; Gerritsen GC; Mann KM; Owen SP Cancer Chemother Rep; 1965 Oct; 48():1-6. PubMed ID: 4953644 [No Abstract] [Full Text] [Related]
14. New drugs on the horizon in bronchogenic carcinoma. Carter SK Cancer; 1972 Nov; 30(5):1402-9. PubMed ID: 4117256 [No Abstract] [Full Text] [Related]
15. Discovery of a highly potent orally bioavailable imidazo-[1, 2-a]pyrazine Aurora inhibitor. Yu T; Zhang Y; Kerekes AD; Tagat JR; Doll RJ; Xiao Y; Esposite S; Hruza A; Belanger DB; Voss M; Rainka MP; Basso A; Liu M; Liang L; Sui N; Prelusky D; Rindgen D; Zhang L Bioorg Med Chem Lett; 2018 May; 28(8):1397-1403. PubMed ID: 29545102 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents. Heyes J; Catherall EJ; Cockburn A Cancer Chemother Rep; 1973; 57(3):263-8. PubMed ID: 4751253 [No Abstract] [Full Text] [Related]
17. Aryl-2-halogenoalkylamines. 23. Derivatives of oxanilic acid and salicylic acid: synthesis and antineoplastic activities. Artico M; Ross WC Biochem Pharmacol; 1968 Jun; 17(6):883-91. PubMed ID: 5661351 [No Abstract] [Full Text] [Related]
18. [Experimental methodology for the selection of potential anticancer agents]. Pérez Mínguez F; Llombart Bosch A Rev Esp Oncol; 1982; 29(4):593-602. PubMed ID: 6927364 [TBL] [Abstract][Full Text] [Related]
19. [Synthesis and antibacterial and antitumoral activity of some methylhydrazonium salts of pyrimidine bases and their analogues (author's transl)]. Golovinsky E; Karamanov G; Spassovska N; Maneva L; Spassov A Pharmazie; 1982 May; 37(5):355-6. PubMed ID: 7111362 [TBL] [Abstract][Full Text] [Related]
20. Pharmacology of polyriboinosinic: polyribocytidylic acid, a new antiviral and antitumor agent. Adamson RH; Fabro S; Homan ER; O'Gara RW; Zendzian RP Antimicrob Agents Chemother (Bethesda); 1969; 9():148-52. PubMed ID: 4990370 [No Abstract] [Full Text] [Related] [Next] [New Search]